Asim Shabbir Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

University of Arkansas at Fayetteville

faculty

44 h-index 382 pubs 7,610 cited

Research Areas

Cancer-related molecular mechanisms research Gastric Cancer Health Disparities and Outcomes Diet and metabolism studies Cardiovascular Function and Risk Factors Meta-analysis and systematic reviews Cancer Genomics and Diagnostics

Links

ORCID Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Asim Shabbir's research program focuses on cancer-related molecular mechanisms, with specific investigations into gastric cancer. His work has examined the role of the Hedgehog transcriptional effector GLI in mediating mTOR-induced PD-L1 expression within gastric cancer organoids. Further contributions include the development of a single-cell atlas detailing lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer.

Beyond oncology, Shabbir's research extends to metabolic health and surgical outcomes. He has been involved in developing risk prediction models for mortality following esophagectomy for cancer and has contributed to consensus statements on bariatric surgical procedures, including mini gastric bypass and sleeve gastrectomy. His work also includes the regulation of adipogenic differentiation and adipose tissue inflammation by interferon regulatory factor 3, and recommendations for the screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in patients with cardiovascular disease.

With an h-index of 44 and over 7,600 citations across 382 publications, Shabbir is recognized as a highly cited researcher. He maintains an active laboratory website and has demonstrated recent activity in his field.

Metrics

h-index: 44
Publications: 382
Citations: 7,610

Selected Publications

Ceramide-induced FGF13 impairs systemic metabolic health (2025) DOI
International expert consensus on the current status and future prospects of artificial intelligence in metabolic and bariatric surgery (2025) DOI
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach (2024) DOI
Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease (2024) DOI
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden (2024) DOI
Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes (2024) DOI
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases (2024) DOI
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals (2024) DOI
Metabolic and Bariatric Surgeon Criteria—An International Experts’ Consensus (2024) DOI
Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus (2024) DOI
Sex differences in optimal medical therapy following invasive angiography for coronary artery disease (2024) DOI
Technical Variations and Considerations around OAGB in IFSO-APC and IFSO-MENAC Chapters, an Expert Survey (2024) DOI
Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation (2024) DOI
The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy (2024) DOI
The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery—An International Expert Survey (2024) DOI